Cellectar Biosciences Price to Free Cash Flow Ratio 2010-2024 | CLRB
Historical price to free cash flow ratio values for Cellectar Biosciences (CLRB) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cellectar Biosciences Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-03-31 | 0.32 | 0.00 | |
| 2024-12-31 | 0.30 | $-1.28 | 0.00 |
| 2024-09-30 | 2.14 | $-1.58 | 0.00 |
| 2024-06-30 | 2.50 | $-2.15 | 0.00 |
| 2024-03-31 | 3.98 | $-2.54 | 0.00 |
| 2023-12-31 | 2.77 | $-2.72 | 0.00 |
| 2023-09-30 | 2.64 | $-2.74 | 0.00 |
| 2023-06-30 | 1.95 | $-3.13 | 0.00 |
| 2023-03-31 | 1.43 | $-3.42 | 0.00 |
| 2022-12-31 | 1.71 | $-3.61 | 0.00 |
| 2022-09-30 | 3.36 | $-4.01 | 0.00 |
| 2022-06-30 | 4.04 | $-3.67 | 0.00 |
| 2022-03-31 | 6.88 | $-3.93 | 0.00 |
| 2021-12-31 | 6.64 | $-4.09 | 0.00 |
| 2021-09-30 | 9.25 | $-6.24 | 0.00 |
| 2021-06-30 | 11.90 | $-4.48 | 0.00 |
| 2021-03-31 | 16.10 | $-4.30 | 0.00 |
| 2020-12-31 | 20.80 | $-7.06 | 0.00 |
| 2020-09-30 | 12.40 | $-9.49 | 0.00 |
| 2020-06-30 | 12.80 | $-12.18 | 0.00 |
| 2020-03-31 | 13.33 | $-13.11 | 0.00 |
| 2019-12-31 | 22.50 | $-15.27 | 0.00 |
| 2019-09-30 | 20.00 | $-22.19 | 0.00 |
| 2019-06-30 | 21.80 | $-14.52 | 0.00 |
| 2019-03-31 | 23.50 | $-26.70 | 0.00 |
| 2018-12-31 | 15.50 | $-39.74 | 0.00 |
| 2018-09-30 | 30.00 | $-44.78 | 0.00 |
| 2018-06-30 | 62.00 | $-69.75 | 0.00 |
| 2018-03-31 | 113.50 | $-74.54 | 0.00 |
| 2017-12-31 | 137.00 | $-81.01 | 0.00 |
| 2017-09-30 | 167.00 | $-144.10 | 0.00 |
| 2017-06-30 | 163.00 | $-149.64 | 0.00 |
| 2017-03-31 | 227.00 | $-16.15 | 0.00 |
| 2016-12-31 | 122.00 | $-191.33 | 0.00 |
| 2016-09-30 | 271.00 | $-274.86 | 0.00 |
| 2016-06-30 | 344.00 | $-537.24 | 0.00 |
| 2016-03-31 | 341.83 | $-942.11 | 0.00 |
| 2015-12-31 | 735.00 | $-1,057.76 | 0.00 |
| 2015-09-30 | 1970.00 | $-1,484.77 | 0.00 |
| 2015-06-30 | 2880.00 | $-929.02 | 0.00 |
| 2015-03-31 | 3110.00 | $-1,338.28 | 0.00 |
| 2014-12-31 | 3090.00 | $-1,931.35 | 0.00 |
| 2014-09-30 | 2220.00 | $-2,364.69 | 0.00 |
| 2014-06-30 | 6390.00 | $-3,537.99 | 0.00 |
| 2014-03-31 | 7800.00 | $-3,464.71 | 0.00 |
| 2013-12-31 | 7400.00 | $-3,328.25 | 0.00 |
| 2013-09-30 | 7200.00 | $-3,276.90 | 0.00 |
| 2013-06-30 | 9200.00 | $-4,649.33 | 0.00 |
| 2013-03-31 | 9210.00 | $-4,023.08 | 0.00 |
| 2012-12-31 | 14800.00 | $-3,250.26 | 0.00 |
| 2012-09-30 | 21000.00 | $-2,277.13 | 0.00 |
| 2012-06-30 | 23800.00 | $-0.22 | 0.00 |
| 2012-03-31 | 17000.00 | $-0.28 | 0.00 |
| 2011-12-31 | 8800.00 | $-0.25 | 0.00 |
| 2011-09-30 | 25400.00 | $-866.58 | 0.00 |
| 2011-06-30 | 26000.00 | $-866.57 | 0.00 |
| 2011-03-31 | 54468.00 | $-862.93 | 0.00 |
| 2010-12-31 | 79254.00 | $-866.67 | 0.00 |
| 2010-09-30 | 159120.00 | $-0.26 | 0.00 |
| 2010-06-30 | 321300.00 | $-0.21 | 0.00 |
| 2010-03-31 | 556920.00 | $-3.76 | 0.00 |
| 2009-12-31 | 1000000.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.015B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |